PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsdrug-induced dyskinesia
MeSH D004409 - drug-induced dyskinesia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020258:Neurotoxicity syndromes
0 Companies
0 Drugs
Success rate
D020820:Dyskinesias
56 Companies
12 Drugs
$
Success rate
D064420:Drug-related side effects and adverse reactions
1 Company
1 Drug
$
Success rate
D004409: 
Drug-induced dyskinesia
25 Companies
1 Drug
$
Success rate
D000071057:Tardive dyskinesia
3 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmantadine Amantadine  1991-08-23   
CiplaAmantadine Amantadine  2016-09-30   
SandozAmantadine Amantadine  1987-02-18   
Xttrium LaboratoriesAmantadine Amantadine  1998-12-24   
Zydus TherapeuticsAmantadine Amantadine  2016-05-31   
Alembic PharmaceuticalsAmantadine Amantadine  2017-06-21   
Chartwell PharmaceuticalsAmantadine Amantadine  1993-06-28   
Strides Pharma GlobalAmantadine Amantadine  2017-06-09   
BionPharmaAmantadine Amantadine  2008-05-29   
Adamas PharmaceuticalsAmantadine Gocovri 2025-11-23 2017-08-24   
Amantadine Osmolex 2025-11-23 2018-02-16   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/3
Phase 2
17%
1/6
Phase 3
60%
3/5
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Adamas Pharmaceuticals
Amantadine
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use